The STELLAR trial protocol: a prospective multicentre trial for Richter’s syndrome consisting of a randomised trial investigation CHOP-R with or without acalabrutinib for newly diagnosed RS and a single-arm platform study for evaluation of novel agents in relapsed disease

Appleby, N, Eyre, TA, Cabes, M et al. (7 more authors) (2019) The STELLAR trial protocol: a prospective multicentre trial for Richter’s syndrome consisting of a randomised trial investigation CHOP-R with or without acalabrutinib for newly diagnosed RS and a single-arm platform study for evaluation of novel agents in relapsed disease. BMC Cancer, 19 (1). 471. ISSN 1471-2407

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © The Author(s). 2019. This is an open access article under the terms of the Creative Commons Attribution 4.0 International (CC BY 4.0) (https://creativecommons.org/licenses/by/4.0/) The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Keywords: Richter syndrome; Richter transformation, acalabrutinib; BTK inhibitor, chronic lymphocytic leukaemia; CHOP-R
Dates:
  • Accepted: 14 May 2019
  • Published (online): 20 May 2019
  • Published: 20 May 2019
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > Institute of Molecular Medicine (LIMM) (Leeds) > Section of Experimental Haematology (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 17 Feb 2020 13:51
Last Modified: 17 Feb 2020 13:51
Status: Published
Publisher: BMC
Identification Number: https://doi.org/10.1186/s12885-019-5717-y

Share / Export

Statistics